The convergence of artificial intelligence and biological data is sparking a revolution in life sciences, drastically reducing the time required for drug discovery and genetic analysis. The AI in Bioinformatics Market was valued at USD 5.45 billion in 2024 and is projected to skyrocket to USD 88.17 billion by 2032, growing at an extraordinary CAGR of...